PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-272.88%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
77.92%
D&A growth of 77.92% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
100.00%
Deferred tax growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
49.65%
SBC growth of 49.65% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
56.13%
Working capital of 56.13% while Healthcare median is zero at 0.00%. Walter Schloss would check if expansions or cost inefficiencies cause that difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.43%
AP growth of 59.43% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
-0.47%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
85.22%
Growth of 85.22% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or one-off revaluations explaining the difference.
-64.88%
Negative CFO growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
82.30%
CapEx growth of 82.30% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or upgrades behind the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.30%
Investing flow of 82.30% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or deals prompting that difference.
-39.13%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
-90.34%
We reduce issuance yoy while Healthcare median is 0.00%. Seth Klarman might see an advantage in preserving per-share value unless expansions are neglected.
No Data
No Data available this quarter, please select a different quarter.